Charles Schwab’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,857
| Closed | -$40.9K | – | 3577 |
|
|
2023
Q2 | $40.9K | Sell |
13,857
-81,240
| -85% | -$240K | ﹤0.01% | 3444 |
|
|
2023
Q1 | $238K | Buy |
95,097
+6,295
| +7% | +$15.7K | ﹤0.01% | 3129 |
|
|
2022
Q4 | $282K | Hold |
88,802
| – | – | ﹤0.01% | 3127 |
|
|
2022
Q3 | $264K | Hold |
88,802
| – | – | ﹤0.01% | 3129 |
|
|
2022
Q2 | $271K | Buy |
88,802
+3,405
| +4% | +$10.4K | ﹤0.01% | 3201 |
|
|
2022
Q1 | $1.15M | Buy |
85,397
+847
| +1% | +$11.4K | ﹤0.01% | 2797 |
|
|
2021
Q4 | $1.1M | Buy |
84,550
+2,785
| +3% | +$36.3K | ﹤0.01% | 2871 |
|
|
2021
Q3 | $767K | Sell |
81,765
-70,221
| -46% | -$659K | ﹤0.01% | 2978 |
|
|
2021
Q2 | $1.56M | Buy |
151,986
+40,718
| +37% | +$417K | ﹤0.01% | 2793 |
|
|
2021
Q1 | $2.05M | Buy |
111,268
+27,518
| +33% | +$506K | ﹤0.01% | 2655 |
|
|
2020
Q4 | $2.87M | Buy |
+83,750
| New | +$2.87M | ﹤0.01% | 2471 |
|